News
 
Pharmaceuticals Newsletter - May 21 to May 25, 2012
India Infoline News Service/19:38,May 25, 2012
Piramal Healthcare Limited announced today that Phase I clinical trial data for its investigational new drug candidate P1446A-05 will be presented at the Annual Meeting of the American Society for Clinical Oncology (ASCO) being convened in Chicago from June 1-5, 2012.
list India Infoline Weekly Newsletter - May 25, 2012
list Pfizer recalls Advil bottles from distributor centers
list Teva outlines financial estimates for 2012
list Ranbaxy hires advisers for resolving consent decree with USFDA

Calendar

May-2012
M T W T F S S
21 22 23 24 25 26 27
Economic Events
list Corporate Service Price (YoY)
list Hometrack Housing Survey (MoM)
Results
list No result today
IPO
listNo IPO today
 

IIFL recommends ‘Add’ on ONGC

India Infoline News Service / 09:01 , Feb 10, 2012

Domestic crude production declined 1.4% QoQ and gas production was flat QoQ.

IIFL Institutional Equities, a part of the IIFL Group, one of the leading players in the Indian financial services space, recommends ‘‘Add’ on  ONGC
 
The company’s 3QFY12 Ebitda came in 4% ahead of estimates. However, PAT was 5% below estimate on higher tax rate. ONGC accounted for extraordinary gains of Rs31.4bn relating to royalties borne on Cairn India’s behalf until 2QFY12, according to IIFL report.
 
IIFL said, “We expect ONGC to bear Rs185bn of under-recoveries for 4QFY12. We believe continued uncertainty on the final formula for subsidy sharing and on the possible share sale by government via the auction route would keep the stock price range bound”.
 
Domestic crude production declined 1.4% QoQ and gas production was flat QoQ. OVL’s production suffered due to: 1) ongoing conflict in Sudan (down 70kbpd from peak); and 2) sanctions imposed by the US and EU on Syria (down to zero), IIFL added.
 
The report was published by IIFL’s Institutional Equities Research desk.

 



Rate This Article Rate 1 Rate 2 Rate 3 Rate 4 Rate 5